Canada confirms purchase of 358 million vaccines for COVID-19

The Canadian Prime Minister, Justin trudeau, announced this Friday the signing of a new contract for the acquisition of 76 million units of a future vaccine against the coronavirus, which will be produced by the Canadian company Medicago, which brings to 358 million the doses that Canada has already acquired from different pharmaceutical companies.

In addition to the 76 million doses of Medicago vaccine, which is developing the drug with Britain’s GlaxoSmithKline, Canada previously signed contracts for the purchase of vaccines from AstraZeneca, Johnson & Johnson, Novavax, Sanofi, Moderna, and Pfizer.

Waiting for vaccines

The 358 million doses of vaccines against the coronavirus acquired so far, contrasts with the 37.6 million inhabitants that Canada has.

Trudeau stated that the first doses of the vaccines purchased by Canada, could be available in early 2021, although mass distribution to the population would take longer to arrive.

“We have worked hard to ensure that we can have access to vaccines when they are discovered. We have signed six agreements cThere are several companies around the world that are developing potential vaccines, “Trudeau explained during a press conference.

“We are waiting for those vaccines to be effective and safe for Canadians. Nothing will be distributed in Canada until the Ministry of Health is satisfied that the safety of Canadians is guaranteed, “added the Canadian prime minister.

Millionaire investments

Trudeau added that the vaccines won’t be ready for several months. “I think it is reasonable to expect these vaccines to start arriving early next year but they will be small doses that will be distributed to the priority populations“he continued.

Canada will allocate 214 million Canadian dollars (163 million US dollars) for the purchase of the domestically developed vaccines, including that of Medicago, which is the first possible vaccine under development in the North American country.

In addition, Ottawa will invest 173 million Canadian dollars (132 million US dollars) for Medicago to build in the province of Quebec a plant for the production of vaccines.

Medicago, which is funded by the US Pentagon and in which the tobacco company participates Philip Morris International, is developing a vaccine that, unlike the products of other pharmaceutical companies, uses plants as the base for its medicine.



Related Articles